Metlife Inc (NYSE: MET) has seen a rise in its stock price by 0.81 in relation to its previous close of 78.68. However, the company has experienced a 0.37% gain in its stock price over the last five trading sessions. zacks.com reported 2025-05-30 that MetLife (MET) reported earnings 30 days ago. What’s next for the stock?
Is It Worth Investing in Metlife Inc (NYSE: MET) Right Now?
Metlife Inc (NYSE: MET) has a higher price-to-earnings ratio of 12.91x compared to its average ratio. MET has 36-month beta value of 0.84. Analysts have mixed views on the stock, with 7 analysts rating it as a “buy,” 5 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for MET is 561.52M, and currently, short sellers hold a 1.24% ratio of that float. The average trading volume of MET on June 04, 2025 was 3.62M shares.
MET’s Market Performance
The stock of Metlife Inc (MET) has seen a 0.37% increase in the past week, with a 1.94% rise in the past month, and a -2.75% fall in the past quarter. The volatility ratio for the week is 0.66%, and the volatility levels for the past 30 days are at 1.42% for MET. The simple moving average for the past 20 days is 0.53% for MET’s stock, with a -1.68% simple moving average for the past 200 days.
Analysts’ Opinion of MET
Many brokerage firms have already submitted their reports for MET stocks, with BMO Capital Markets repeating the rating for MET by listing it as a “Market Perform.” The predicted price for MET in the upcoming period, according to BMO Capital Markets is $97 based on the research report published on January 23, 2025 of the current year 2025.
TD Cowen, on the other hand, stated in their research note that they expect to see MET reach a price target of $97. The rating they have provided for MET stocks is “Buy” according to the report published on October 09th, 2024.
Barclays gave a rating of “Overweight” to MET, setting the target price at $91 in the report published on September 05th of the previous year.
MET Trading at 2.91% from the 50-Day Moving Average
After a stumble in the market that brought MET to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.93% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MET starting from PAPPAS BILL, who sale 26,000 shares at the price of $80.49 back on May 12 ’25. After this action, PAPPAS BILL now owns 66,744 shares of Metlife Inc, valued at $2,092,683 using the latest closing price.
PAPPAS BILL, the Officer of Metlife Inc, proposed sale 26,000 shares at $80.49 during a trade that took place back on May 12 ’25, which means that PAPPAS BILL is holding shares at $2,092,683 based on the most recent closing price.
Stock Fundamentals for MET
Current profitability levels for the company are sitting at:
- 0.09 for the present operating margin
- 1.0 for the gross margin
The net margin for Metlife Inc stands at 0.06. The total capital return value is set at 0.01. Equity return is now at value 16.08, with 0.66 for asset returns.
Based on Metlife Inc (MET), the company’s capital structure generated 0.35 points at debt to capital in total, while cash flow to debt ratio is standing at 1.13. The debt to equity ratio resting at 0.55. The interest coverage ratio of the stock is 6.25.
Currently, EBITDA for the company is 6.66 billion with net debt to EBITDA at -2.12. When we switch over and look at the enterprise to sales, we see a ratio of 0.64. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.13.
Conclusion
To put it simply, Metlife Inc (MET) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
